Literature DB >> 26481388

[Telephone enquiries on the topic of malignant hyperthermia: Evaluation of the content and subsequent diagnostic results at the MH Center Leipzig].

B Petersen1, T Busch1, C-D Meinecke1, B Börge1, K Kluba1, U X Kaisers1, H Rüffert2,3.   

Abstract

BACKGROUND: Malignant hyperthermia (MH) is an autosomal dominant metabolic myopathy. The in vitro contracture test (IVCT) is still considered to be the gold standard for diagnosing a disposition for MH. However, advances in genetic testing for MH disposition have supplemented or even replaced the invasive procedure of the IVCT. Information about MH can be obtained by either contacting the hotline for MH as a nationwide 24 h/7 days a week service or one of the regional MH centers.
METHODS: The protocols of telephone conversations concerning MH at the MH Center University Leipzig were retrospectively analyzed. Data were collected from January 2011 to March 2015. Additionally, the results of the IVCT and genetic testing evolving from the counseling interviews were examined.
RESULTS: A total of 205 telephone calls were documented during the period in question and an IVCT was performed as a consequence of 112 of the telephone calls. The IVCT resulted in 27 individuals being identified as MH susceptible which was subsequently diagnosed in 15 individuals with known familial MH disposition and 12 individuals were identified as new index patients. In 24 individuals a total of 13 different mutations were detected and of these 4 mutations were causative concerning MH. Of the 205 telephone calls 131 were private and 74 of medical professional origin. Among the private enquiries MH disposition within the family was a frequent reason for contacting the MH Center (61.8%). Conversations relating to MH-like symptoms during general anesthesia were carried out with 35.1% of medical doctors and with 22.9% of private callers. Advice about neuromuscular symptoms of unknown genesis was given to 15.3% of private individuals and to 24.3% of medical doctors. Overall MH topics were discussed with 23% (N = 17) of the medical profession and approximately half of these were anesthesiologists (N = 8). Not a single call was documented for the treatment of a suspected MH crisis.
CONCLUSION: Private individuals and families affected by a MH disposition often showed good compliance with respect to counseling and diagnostics for MH and contacted the MH center more often than medical doctors. A more comprehensive cooperation with the medical profession is preferable and necessary to obtain a systematic and broad synopsis of characteristic and uncharacteristic signs and symptoms of MH. The telephone conversations analyzed as well as the diagnostic results (IVCT and genetic testing) underline that MH disposition is still a current and relevant topic.

Entities:  

Keywords:  Anesthesia related incident; Genetic testing; In vitro contracture test; Malignant hyperthermia; Telephone hotline

Mesh:

Year:  2015        PMID: 26481388     DOI: 10.1007/s00101-015-0099-2

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  36 in total

1.  Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.

Authors:  Jose Miguel Eltit; Roger A Bannister; Ong Moua; Francisco Altamirano; Philip M Hopkins; Isaac N Pessah; Tadeusz F Molinski; Jose R López; Kurt G Beam; Paul D Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

Review 2.  Mutations in RYR1 in malignant hyperthermia and central core disease.

Authors:  Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopkins
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

3.  Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.

Authors:  N Monnier; V Procaccio; P Stieglitz; J Lunardi
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

Review 4.  Genetics of malignant hyperthermia.

Authors:  Barbara W Brandom
Journal:  ScientificWorldJournal       Date:  2006-12-28

5.  Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis.

Authors:  F Wappler; M Fiege; M Steinfath; K Agarwal; J Scholz; S Singh; J Matschke; J Schulte Am Esch
Journal:  Anesthesiology       Date:  2001-01       Impact factor: 7.892

6.  Incidence of malignant hyperthermia in Denmark.

Authors:  H Ording
Journal:  Anesth Analg       Date:  1985-07       Impact factor: 5.108

7.  A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.

Authors: 
Journal:  Br J Anaesth       Date:  1984-11       Impact factor: 9.166

Review 8.  [Malignant hyperthermia. The ugly].

Authors:  H Rüffert; M Wehner; C Deutrich; D Olthoff
Journal:  Anaesthesist       Date:  2007-09       Impact factor: 1.041

9.  Malignant hyperthermia in the intensive care setting.

Authors:  Frank Schuster; Susanne Moegele; Stephan Johannsen; Norbert Roewer
Journal:  Crit Care       Date:  2014-02-26       Impact factor: 9.097

Review 10.  Malignant hyperthermia.

Authors:  Henry Rosenberg; Mark Davis; Danielle James; Neil Pollock; Kathryn Stowell
Journal:  Orphanet J Rare Dis       Date:  2007-04-24       Impact factor: 4.123

View more
  1 in total

Review 1.  [Pharmacogenetics in anesthesia and intensive care medicine : Clinical and legal challenges exemplified by malignant hyperthermia].

Authors:  W Klingler; E Pfenninger
Journal:  Anaesthesist       Date:  2016-05       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.